<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35527459</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1001-0939</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>45</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>12</Day>
            </PubDate>
          </JournalIssue>
          <Title>Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases</Title>
          <ISOAbbreviation>Zhonghua Jie He He Hu Xi Za Zhi</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Comparison of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In Tube in the diagnosis of pulmonary tuberculosis].</ArticleTitle>
        <Pagination>
          <StartPage>445</StartPage>
          <EndPage>452</EndPage>
          <MedlinePgn>445-452</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.cn112147-20220206-00095</ELocationID>
        <Abstract>
          <AbstractText><b>Objective:</b> To compare the screening value of QuantiFERON-TB Gold Plus (QFT-Plus) and QuantiFERON®-TB Gold in tube (QFT-GIT) in the auxiliary diagnosis of pulmonary tuberculosis (TB). <b>Methods:</b> A screening test was performed. Patients who were hospitalized in Guangzhou Chest Hospital and underwent QFT-GIT testing from October to December 2020 were prospectively included as research subjects, QFT-Plus testing was added. And the basic information, clinical manifestations, laboratory test results, imaging examinations and other data of these patients were collected. A total of 207 patients were included and divided into tuberculosis group and non-tuberculosis group according to these data. There were 124 cases in the tuberculosis group (94 confirmed patients and 30 clinically diagnosed patients), including 90 males and 34 females, aged 18-93 years, with a median age of 57 (38, 67) years. The non-tuberculosis group included 83 patients (16 patients with non-tuberculous <i>Mycobacteria</i> and 67 patients with other lung diseases), including 49 males and 34 females, with a median age of 60 (51, 68) years. The confirmed patients were subdivided into three grades of low, medium and high <i>Mycobacteriam tuberculosis</i> (MTB) bacterial load, and three grades of mild, moderate and severe pulmonary tuberculosis. The results of QFT-Plus and QFT-GIT were compared, and the levels of IFN-γ in different antigen tubes were compared. Differences between different groups were compared using Mann-Whitney <i>U</i> test and Kruskal-Wallis <i>H</i> test. <b>Results:</b> The QFT-Plus showed a high degree of agreement with the QFT-GIT (<i>κ</i>=0.786, 95%<i>CI</i>: 0.740-0.832), while the main discordant result was QFT-GIT negative/QFT-Plus positive, accounting for 15/17. The sensitivity of QFT-GIT was 80.7%(95%<i>CI</i>: 0.706-0.880), the specificity was 76.3%(95%<i>CI</i>: 0.649-0.850), the positive predictive value was 79.8%(95%<i>CI</i>: 0.697-0.873), and the negative predictive value was 77.3%(95%<i>CI</i>: 0.659-0.859), repectively. QFT-Plus showed a sensitivity of 84.3%(95%<i>CI</i>: 0.743-0.910), a specificity of 78.8% (95%<i>CI</i>: 0.679-0.868), and a positive predictive value of 80.5%(95%<i>CI</i>: 0.703-0.879), the negative predictive value being 82.9%(95%<i>CI</i>: 0.721-0.902), slightly improved to that of the QFT-GIT. Also, this study found that there were significant differences in IFN-γ values between different MTB load or disease severity (<i>P</i>&lt;0.05). <b>Conclusions:</b> There is a good consistency between the QFT-Plus test and the QFT-GIT test, both of which show good application value in the auxiliary diagnosis of pulmonary tuberculosis. Moreover, because of the addition of tuberculosis-specific CD8 cell antigen, the QFT-Plus test has higher sensitivity, lower uncertainty and more application value. This study also found that the bacterial load and disease severity of patients with pulmonary tuberculosis may have a certain correlation with the measured value of IFN-γ.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>X Y</ForeName>
            <Initials>XY</Initials>
            <AffiliationInfo>
              <Affiliation>Graduate School, Guangzhou Medical University, Guangzhou 511436, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Su</LastName>
            <ForeName>B Y</ForeName>
            <Initials>BY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathogenic Laboratory, Guangzhou Chest Hospital, Guangzhou 510095, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Z Y</ForeName>
            <Initials>ZY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathogenic Laboratory, Guangzhou Chest Hospital, Guangzhou 510095, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kuang</LastName>
            <ForeName>H B</ForeName>
            <Initials>HB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Tuberculosis, Guangzhou Chest Hospital, Guangzhou 510095, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guan</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathogenic Laboratory, Guangzhou Chest Hospital, Guangzhou 510095, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cao</LastName>
            <ForeName>Z Z</ForeName>
            <Initials>ZZ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathogenic Laboratory, Guangzhou Chest Hospital, Guangzhou 510095, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tan</LastName>
            <ForeName>Y J</ForeName>
            <Initials>YJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathogenic Laboratory, Guangzhou Chest Hospital, Guangzhou 510095, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>chi</Language>
        <PublicationTypeList>
          <PublicationType UI="D003160">Comparative Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>China</Country>
        <MedlineTA>Zhonghua Jie He He Hu Xi Za Zhi</MedlineTA>
        <NlmUniqueID>8712226</NlmUniqueID>
        <ISSNLinking>1001-0939</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>82115-62-6</RegistryNumber>
          <NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007371" MajorTopicYN="N">Interferon-gamma</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059425" MajorTopicYN="N">Interferon-gamma Release Tests</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055985" MajorTopicYN="Y">Latent Tuberculosis</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014374" MajorTopicYN="N">Tuberculin Test</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014397" MajorTopicYN="Y">Tuberculosis, Pulmonary</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <OtherAbstract Type="Publisher" Language="chi">
        <AbstractText><b>目的：</b> 比较QuantiFERON-TB Gold Plus（QFT-Plus）与QuantiFERON-TB Gold in tube（QFT-GIT）在肺结核辅助诊断中的筛查价值。 <b>方法：</b> 筛检试验。前瞻性纳入2020年10—12月在广州市胸科医院住院的并进行QFT-GIT检测的患者作为研究对象，增加QFT-Plus检测，并收集这些患者的基本信息、临床表现、实验室检测结果和影像检查等资料。共纳入207例患者，分为结核组和非结核组。结核组共124例（包括94例确诊患者和30例临床诊断患者），其中男90例，女34例，年龄18~93岁，中位年龄57（36，66）岁。非结核组共83例（包括非结核分枝杆菌患者16例和其他肺部疾病患者67例），其中男49例，女34例，中位年龄60（51，68）岁。将确诊患者再分为低、中、高MTB荷菌量3级，和轻、中、重度肺结核3级。比较QFT-Plus与QFT-GIT检测结果，对比分析不同抗原管内γ-干扰素水平。各组间的差异采用Mann-Whitney <i>U</i>检验和Kruskal-Wallis <i>H</i>检验进行比较。 <b>结果：</b> QFT-Plus与QFT-GIT检测的结果的一致性较好（<i>κ</i>=0.786，95%<i>CI</i>：0.740~0.832），不一致率仅为8%，不一致的结果主要表现为QFT-GIT阴性/QFT-Plus阳性，占全部不一致的15/17。其中，QFT-GIT检测：敏感度为80.7%（95%<i>CI</i>：0.706~0.880）、特异度为76.3%（95%<i>CI</i>：0.649~0.850）、阳性预测值为79.8%（95%<i>CI</i>：0.697~0.873）、阴性预测值为77.3%（95%<i>CI</i>：0.659~0.859）；而QFT-Plus检测：敏感度为84.3%（95%<i>CI</i>：0.743~0.910）、特异度为78.8%（95%<i>CI</i>：0.679~0.868）、阳性预测值为80.5%（95%<i>CI</i>：0.703~0.879）、阴性预测值为82.9%（95%<i>CI</i>：0.721~0.902），均高于QFT-GIT检测结果。不同结核分枝杆菌荷菌量及疾病严重程度患者之间，抗原管检测的γ干扰素水平差异均有统计学意义（均<i>P</i>&lt;0.05）。 <b>结论：</b> QFT-Plus检测和QFT-GIT检测之间有着较好的一致性，在肺结核的辅助诊断中有良好的应用价值；因为添加了结核特异性CD8细胞抗原，QFT-Plus检测有着更高的敏感度、更低的不确定性和更好的应用价值。本研究还发现，肺结核患者的荷菌量和疾病严重程度可能与γ-干扰素水平有一定相关性。.</AbstractText>
      </OtherAbstract>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>9</Day>
          <Hour>2</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35527459</ArticleId>
        <ArticleId IdType="doi">10.3760/cma.j.cn112147-20220206-00095</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
